87 related articles for article (PubMed ID: 4477168)
1. [Experimental and clinical studies on effects of glucagon on the ischmic heart].
Asai Y
Nihon Kyobu Geka Gakkai Zasshi; 1974 Dec; 22(12):1158-71. PubMed ID: 4477168
[No Abstract] [Full Text] [Related]
2. [Comparative effects of norepinephrine, isoproterenol and dopamine on myocardial function and metabolism during experimental myocardial infarction (author's transl)].
Matsuura H
Nihon Naika Gakkai Zasshi; 1976 Jan; 65(1):30-9. PubMed ID: 987126
[No Abstract] [Full Text] [Related]
3. [Shock and MDF].
Shimizu R
Kokyu To Junkan; 1972 May; 20(5):433-41. PubMed ID: 4574841
[No Abstract] [Full Text] [Related]
4. Drug therapy in cardiogenic shock.
Ramdohr B
Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
[No Abstract] [Full Text] [Related]
5. Glucagon in the treatment of cardiogenic shock following acute myocardial infarction.
O'Brien ET; Howarth E; Singh SP
J Ir Med Assoc; 1973 Aug; 66(15):415-7. PubMed ID: 4727938
[No Abstract] [Full Text] [Related]
6. [Glucagon and cardiogenic shock].
Perrelet C; Friedemann M; Aepli R
Schweiz Med Wochenschr; 1970 Dec; 100(50):2168-70. PubMed ID: 5526158
[No Abstract] [Full Text] [Related]
7. Rational therapeutic approach to cardiogenic shock.
Wiener L
Cardiovasc Clin; 1974; 6(2):223-37. PubMed ID: 4613459
[No Abstract] [Full Text] [Related]
8. [Cardiogenic shock and severe hypotension in acute myocardial infarct treated with glucagon. Preliminary experience from a coronary unit].
Amtorp O; Christiansen I; Wennevold A
Ugeskr Laeger; 1971 May; 133(18):867-70. PubMed ID: 5577747
[No Abstract] [Full Text] [Related]
9. [Experimental and clinical studies of IABP in ischemic heart (author's transl)].
Shigemori R
Nihon Kyobu Geka Gakkai Zasshi; 1979 Sep; 27(9):1221-34. PubMed ID: 501168
[No Abstract] [Full Text] [Related]
10. [Glucagon. A new cardioactive drug].
Guerricchio G
Minerva Med; 1974 Oct; 65(72):3799-803. PubMed ID: 4607692
[No Abstract] [Full Text] [Related]
11. [Glucagon in the acute stage of myocardial infarct].
Waremboug H; Bertrand ME; Ducloux G; Pauchant M; Ginestet A; Ketelers JY; Carre A; Delbecque H
Arch Mal Coeur Vaiss; 1973 Apr; 66(4):449-56. PubMed ID: 4200209
[No Abstract] [Full Text] [Related]
12. [Glucagon in the treatment of shock].
Kedrowa S
Pol Tyg Lek; 1976 Mar; 31(12):487-9. PubMed ID: 1272935
[No Abstract] [Full Text] [Related]
13. Glucagon as a myocardial stimulant.
Drug Ther Bull; 1970 Oct; 8(20):77-9. PubMed ID: 5487969
[No Abstract] [Full Text] [Related]
14. [Glucagon in cardiogenic shock].
De Ninno F; Celentano V; Giugliano F
Minerva Anestesiol; 1971 May; 37(5):240-6. PubMed ID: 5110768
[No Abstract] [Full Text] [Related]
15. [Cardiovascular effects of glucagon].
Liakishev AA; Golikov AP
Kardiologiia; 1972 Jul; 12(7):128-36. PubMed ID: 4364203
[No Abstract] [Full Text] [Related]
16. Cardiogenic shock and its current treatment.
Willerson JT
Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757
[No Abstract] [Full Text] [Related]
17. [Glucagon and its applications in cardiology].
Bertrand ME; Ketelers JY; Carre A; Warembourg H
Ann Cardiol Angeiol (Paris); 1971; 20(6):705-15. PubMed ID: 5146725
[No Abstract] [Full Text] [Related]
18. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
Takkunen J; Oilinki O; Huhti E; Vuopala U; Koivisto O
Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261
[No Abstract] [Full Text] [Related]
19. [Cardiotonic effects of glucagon].
Robert M; Humair L
Schweiz Med Wochenschr; 1970 Aug; 100(31):1345-52. PubMed ID: 5513359
[No Abstract] [Full Text] [Related]
20. [Treatment of irreversible heart decompensation and cardiogenic shock with glucagon].
Bruni B
Minerva Cardioangiol; 1972; 20(7):419-27. PubMed ID: 5050748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
